We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

First Postoperative Day Review After Uneventful Phacoemulsification

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01247155
First Posted: November 24, 2010
Last Update Posted: November 24, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Veroia General Hospital
November 23, 2010
November 24, 2010
November 24, 2010
Not Provided
Not Provided
Best corrected visual acuity
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
First Postoperative Day Review After Uneventful Phacoemulsification
Not Provided
The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
291 consecutive patients who underwent uneventful phacoemulsification cataract surgery were randomized into two groups: i) Next day review (NDR group, n=146) and ii) No next day review (NNDR group, n=145).
  • Phacoemulsification
  • Complications
  • BCVA
Not Provided
  • first day review
  • non-first day review
Chatziralli IP, Sergentanis TN, Kanonidou E, Papazisis L. First postoperative day review after uneventful phacoemulsification cataract surgery: is it necessary? BMC Res Notes. 2012 Jun 27;5:333. doi: 10.1186/1756-0500-5-333.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

Exclusion Criteria:

Exclusion criteria were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.

Sexes Eligible for Study: All
65 Years to 90 Years   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Greece
 
 
NCT01247155
9151
Not Provided
Not Provided
Not Provided
Not Provided
Veroia General Hospital
Not Provided
Not Provided
Veroia General Hospital
April 2009